| Issue Date | Title | Author(s) | Type | Мp-cat. |
| 2008 | Capecitabine in cisplatin-pretreated metastatic or recurrent squamous cell carcinoma of the cervix - a possible therapy option for obtaining clinically meaningful outcome? | Stamatović, Ljiljana   ; Vasović, Suzana; Karaferić, Anđela; Tomašević, Zorica ; Jelić, Svetislav | Conference Paper | |
| 2008 | Expression of HER2-neu, estrogen and progesterone receptors, CA 125 and CA 19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary | Karaferić, Anđela; Jovanović, Danica; Jelić, Svetislav | Conference Paper | |
| 2009 | Expression of HER2/neu, estrogen and progesterone receptors, CA 125 and CA19-9 on cancer cell membrane in patients with serous and mucinous carcinoma of the ovary | Karaferić, Anđela; Jovanović, Danica; Jelić, Svetislav | Article | |
| 2008 | PAC regimen in treatment of recurrent ovarian cancer (ROC) | Vasović, Suzana; Stamatović, Ljiljana ; Karaferić, Anđela; Minić, Ivana; Jelić, Svetislav ; Gavrilović, Dušica | Conference Paper | |
| 2009 | Platinum-sensitive relapsed epithelial ovarian cancer - how much does the treatment-free interval matter? | Milović, Marijana ; Stamatović, Ljiljana ; Vasović, Suzana; Karaferić, Anđela; Jelić, Svetislav | Conference Paper | |
| 2012 | The significance of HER-2 amplification and the size and type of pathological unicentric, initially operable clinical stage I and IIA/IIB breast cancer, in determining the treatment strategy | Miletić, Nebojša Đ. ; Golubičić, Ivana ; Gavrilović, Dušica; Džodić, Radan R. ; Pavlović, Tatjana; Nikitović, Marina R. ; Stojiljković, Dejan V. ; Karaferić, Anđela; Pupić, Gordana | Article | |